Related Experiment Videos

Peripheral injection of DNS-RFa, a FMRFa agonist, suppresses morphine-induced analgesia in rats

A B Brussaard1, K S Kits, A Ter Maat

  • 1Department of Biology, Free University, Amsterdam, The Netherlands.

Peptides
|July 1, 1989
PubMed

Insights

The novel peptide DNS-RFa antagonizes morphine-induced pain relief in rats, acting effectively through peripheral injection. This suggests the Arg-Phe-NH2 sequence is crucial for neuronal FMRFa receptor activation in vertebrates.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Research

Background:

  • Previous studies indicated that FMRFa-related peptides, when administered centrally, affect pain perception.
  • The specific role and administration route of DNS-RFa in vertebrate pain modulation remained unclear.

Purpose of the Study:

  • To investigate the effect of DNS-RFa on morphine-induced analgesia in a rat model.
  • To determine if DNS-RFa is effective via peripheral administration and to characterize its dose-dependency.

Main Methods:

  • Rats were administered varying doses of DNS-RFa and morphine.
  • Nociception levels were measured to assess analgesic effects.
  • Comparisons were made with FMRFa administration and DNS-RFa alone.

Main Results:

  • DNS-RFa demonstrated a dose-dependent antagonistic effect on morphine-induced analgesia (ED50 = 0.5 mg/kg).
  • DNS-RFa was effective upon peripheral injection, unlike centrally acting FMRFa peptides.
  • DNS-RFa alone did not alter baseline nociception levels.

Conclusions:

  • DNS-RFa antagonizes morphine analgesia via peripheral administration in rats.
  • The Arg-Phe-NH2 sequence appears essential for DNS-RFa's activity in vertebrates.
  • DNS-RFa can readily penetrate the blood-brain barrier, suggesting central nervous system involvement.

Related Concept Videos